Patent Board Institutes Inter Partes Review Of Allergan Patent
ALEXANDRIA, Va. — An Amneal Pharmaceuticals LLC challenge to a patent covering the dermatologic drug dapsone will proceed before the Patent Trial and Appeal Board, which instituted inter partes review on...To view the full article, register now.
Already a subscriber? Click here to view full article